March 9, 2022 Enzychem Lifesciences Announces Completion of Clinical Study Report (CSR) for Phase 2 Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
March 2, 2022 Enzychem Lifesciences Announces Formation of Corporate Advisory Committee Explore further
March 2, 2022 Enzychem Lifesciences Announces Formation of Corporate Advisory Committee Explore further
